Exane Derivatives’s Ameriprise Financial AMP Stock Holding History

Exane Derivatives’s Portfolio AMP Stock Details AMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-564	Closed	-$169K	–	783
2022 Q1	$169K	Buy	+564	New	+$171K	0.05%	378

Other funds holding AMP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Exane Derivatives's AMP Position: Q2 2022 in Review

Exane Derivatives sold out of Ameriprise Financial (AMP) in Q2 2022, closing a stake of 564 shares — an estimated $169K sold.

Exane Derivatives first reported a position in AMP in Q1 2022 and held it in 1 quarter. The position peaked at $169K in Q1 2022. 954 funds tracked by Wall St. Rank hold AMP as of Q2 2022.

Exane Derivatives reported no remaining Ameriprise Financial position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 564 Ameriprise Financial shares in Q2 2022, an estimated $169K.
Exane Derivatives first reported a position in Ameriprise Financial in Q1 2022 and held it in 1 quarter.
Exane Derivatives's Ameriprise Financial position peaked at $169K in Q1 2022.
954 funds tracked by Wall St. Rank held Ameriprise Financial as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.